Watts, M J <br/><br/>
Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 1998 
 - 1554-60 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1998.16.4.1554  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antigens, CD34--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Blood Cell Count<br/>Blood Transfusion<br/>Bone Marrow--metabolism<br/>Carmustine--therapeutic use<br/>Combined Modality Therapy<br/>Cryopreservation<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--therapeutic use<br/>Female<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Hematopoietic Stem Cell Mobilization--methods<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Male<br/>Melphalan--therapeutic use<br/>Middle Aged<br/>Neoplasms--blood<br/>Podophyllotoxin--therapeutic use<br/>Treatment Failure